822 related articles for article (PubMed ID: 9766506)
1. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
Quentmeier H; Zaborski M; Drexler HG
Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5.
Matsumura I; Ishikawa J; Nakajima K; Oritani K; Tomiyama Y; Miyagawa J; Kato T; Miyazaki H; Matsuzawa Y; Kanakura Y
Mol Cell Biol; 1997 May; 17(5):2933-43. PubMed ID: 9111365
[TBL] [Abstract][Full Text] [Related]
3. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
6. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.
Bacon CM; Tortolani PJ; Shimosaka A; Rees RC; Longo DL; O'Shea JJ
FEBS Lett; 1995 Aug; 370(1-2):63-8. PubMed ID: 7544303
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines.
Liu RY; Fan C; Garcia R; Jove R; Zuckerman KS
Blood; 1999 Apr; 93(7):2369-79. PubMed ID: 10090948
[TBL] [Abstract][Full Text] [Related]
10. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.
Matsumura I; Kanakura Y; Kato T; Ikeda H; Horikawa Y; Ishikawa J; Kitayama H; Nishiura T; Tomiyama Y; Miyazaki H; Matsuzawa Y
Blood; 1996 Oct; 88(8):3074-82. PubMed ID: 8874206
[TBL] [Abstract][Full Text] [Related]
11. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
12. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
Drachman JG; Kaushansky K
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
Drexler HG; Zaborski M; Quentmeier H
Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
[TBL] [Abstract][Full Text] [Related]
17. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
Millot GA; Vainchenker W; Duménil D; Svinarchuk F
Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.
Brizzi MF; Battaglia E; Montrucchio G; Dentelli P; Del Sorbo L; Garbarino G; Pegoraro L; Camussi G
Circ Res; 1999 Apr; 84(7):785-96. PubMed ID: 10205146
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets.
Miyakawa Y; Oda A; Druker BJ; Miyazaki H; Handa M; Ohashi H; Ikeda Y
Blood; 1996 Jan; 87(2):439-46. PubMed ID: 8555464
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways.
Minamiguchi H; Kimura T; Urata Y; Miyazaki H; Bamba T; Abe T; Sonoda Y
Br J Haematol; 2001 Oct; 115(1):175-85. PubMed ID: 11722431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
